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Background: Tracheostomy is one of the most frequently performed procedures in intensive care medicine. The
two main approaches to form a tracheostoma are the open surgical tracheotomy (ST) and the interventional
strategy of percutaneous dilatational tracheotomy (PDT). It is particularly important to the critically ill patients that
both procedures are performed with high success rates and low complication frequencies. Therefore, the aim of
this systematic review is to summarize and analyze existing and relevant evidence for peri- and postoperative
parameters of safety.
Methods/design: A systematic literature search will be conducted in The Cochrane Library, MEDLINE, LILACS, and
Embase to identify all randomized controlled trials (RCTs) comparing peri- and postoperative complications
between the two strategies and to define the strategy with the lower risk of potentially life-threatening events. A
priori defined data will be extracted from included studies, and methodological quality will be assessed according
to the recommendations of the Cochrane Collaboration.
Discussion: The findings of this systematic review with proportional meta-analysis will help to identify the strategy
with the lowest frequency of potentially life-threatening events. This may influence daily practice, and the data may
be implemented in treatment guidelines or serve as the basis for planning further randomized controlled trials.
Considering the critical health of these patients, they will particularly benefit from evidence-based treatment.
Systematic review registration: PROSPERO CRD42015021967
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Tracheostomy is one of the most frequently performed
procedures in intensive care medicine [1, 2]. In 2013,
38,800 tracheostomies were performed in Germany [3]. It
is considered to be a safe technique to achieve sufficient
ventilation for patients who suffer from an obstruction of
the upper airway or who need long-term ventilation [4].* Correspondence: phillip.knebel@med.uni-heidelberg.de
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(http://creativecommons.org/publicdomain/zeTwo different strategies are available for the formation of
a tracheostoma: first, described as early as 1909, open surgi-
cal tracheotomy (ST), which is predominantly performed
by surgeons, and second, initially described in 1985 [5], the
interventional strategy of percutaneous dilatational trache-
otomy (PDT), which is performed by surgeons, internists,
and anesthetists [6–8]. For the PDT, six different tech-
niques that are commonly performed can be distinguished:
balloon dilation tracheostomy (BDT), guide wire dilating
forceps (GWT), multiple dilator tracheostomy (MDT),
rotational dilation tracheostomy (RDT), single-step dilationdistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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(TLT) [9].
Both the surgical and the percutaneous dilatational
strategies provide advantages and disadvantages. Some
complications which can compromise the airway, such as
technical difficulties [9], paratracheal insertion, tracheal
laceration [10–12], pneumothorax [13], loss of airway, and
hemorrhage [14], tend to be unusual for the surgical pro-
cedure but more likely in the percutaneous procedure.
Accordingly, the surgical strategy appears to be beneficial
with regard to the airway safety. In contray, stoma inflam-
mation and infection might be more rare when PDT is
performed [9, 15].
ST immediately secures the newly established access to
the airway. In case of a dislodged tracheal cannula, a re-
intubation is easily possible. In contrast, the PDT is
performed via a small skin incision followed by different
dilatational mechanisms and insertion of the tracheal can-
nula. Disadvantageously, in case of accidental dislocation
of the tracheal cannula, a re-intubation via the newly
achieved access might not be possible. Thus, the life-
threatening situation that the patient cannot be safely
ventilated might occur.
However, time, effort, inconvenience [9, 16], and the
need to transport the critically ill patients to the oper-
ation theater (which is not necessary for the percutan-
eous strategy) have been arguments against ST. But by
now, it has been demonstrated that both PDT and ST
can be safely performed at the bedside by experienced,
skilled practitioners [17].
Numerous common late complications are observed
equally often with both strategies, such as tracheal sten-
osis, tracheal fistulas, and tracheomalacia [9, 18, 19].
Consequently, there is disagreement regarding which
strategy offers the superior benefit/risk ratio for critically ill
patients. Previously published meta-analyses reported con-
flicting results [2, 6, 7, 9, 20, 21], though some older reviews
have not included the currently available percutaneous
techniques. None of the existing reviews succeeded in
including all existing, relevant randomized controlled trials
(RCTs). Additionally, since the last published meta-analysis
in 2014 [9], two recent RCTs with 140 additional patients
have been published.
Until now, the choice of strategy is primarily made by the
preference of the surgeon and not by evidence, as evidence
for the strategy with the best parameters of safety is poor
and conflicting.Methods/design
The protocol of this study is written according to the
Preferred Reporting Items for Systematic Reviews and
Meta-Analysis Protocols 2015 (PRISMA-P 2015) [22].
The following methods will be applied.Systematic literature search methodology
A systematic literature search will be conducted to identify
all relevant RCTs comparing ST and PDT. Database
searches will be done in the Cochrane Library (CENTRAL),
PubMed/MEDLINE, LILACS, and Embase using the fol-
lowing search terms: Tracheotomy/ Tracheostomy /percu-
taneous/ dilatational/ conventional/open/ surgical. Search
terms will be built into effective search strategies using
Medical Subject Headings (MeSH) terms in combination
with free text terms and Boolean operators customized for
each database. The clinical trials register ClinicalTrials.gov
will also be searched to identify potentially unpublished or
ongoing trials in this field. Furthermore, experts in this field
will be asked for further relevant trials.
Published and unpublished RCTs will be searched
and no language restrictions will be applied. If relevant,
non-English language papers will also be included and
translated. All articles will be entered into a library in
the reference software program EndNote (EndNote X7,
Philadelphia).
Study selection
Two review authors will independently screen all records of
potential trials. If the title and abstract suggest relevance,
records will be coded as “retrieve” (eligible or potentially
eligible/unclear). The full-text study reports/publications of
those abstracts will be assessed for eligibility by the same
two review authors independently. Any disagreements will
be resolved through discussion or, if required, consultation
of a third person to reach consent about which studies will
be included for review. Duplicates and collate multiple
reports of the same trial will be identified and excluded so
that each trial rather than each report is the unit of interest
in the review. The selection process will be recorded in
sufficient detail to complete a PRISMA flow diagram and
characteristics of excluded trials table.
Data extraction and management
For extraction of trial characteristics and outcome data, a
standardized data collection form will be used. This form
will be pre-tested on three trials in the review before appli-
cation on the whole set of included trials. Two review
authors will extract data from included trials. The following
trial characteristics will be extracted:
1. Methods: author, year and journal of publication, trial
design (registered: yes/no; number of treatment arms),
total duration of the trial, number of trial centers and
location (mono-center/multicenter, participating
countries), sample size calculation (yes/no/not stated,
power and delta in %), number of and reason for
withdrawals, follow-up time (in days/not stated).
2. Participants: mean age, gender, body mass index,
diagnosis (underlying disease), anatomical cervical
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cervical surgery (yes/no/not stated), inclusion
criteria, exclusion criteria
3. Interventions: performers’ discipline (surgeon/non-
surgeon/not stated) and experience (addressed: yes/
no/in which way) technical details of intervention
(description of technique, location (ICU/OR/not
stated), presence of bronchoscopic or sonographic
guidance (yes/no/not stated))
4. Outcomes: primary and secondary outcomes
specified and collected, exact definitions of
outcomes reported (yes/no)
 Potentially life-threatening events: loss of airway,
false route, tracheal/esophageal injury, major bleeding,
gastric aspiration, pneumothorax/mediastinum,
subcutaneous emphysema, difficult tube change,
other potentially life-threatening events
 Mortality
 Stomal inflammation (defined as edema and/or
erythema and/or tenderness)
 Stomal infection (signs of inflammation and
(possibly culture-positive) purulent discharge
(possibly requiring antibiotic therapy))
 Late complications: tracheal stenosis,
tracheomalacia, tracheocutaneous/esophageal fistula
 Duration of procedure
 Major complications (mortality, technical
difficulties leading to life-threatening events,
loss of airway, false route, tracheal/esophageal
injury, major bleeding, gastric aspiration,
pneumothorax/-mediastinum, subcutaneous
emphysema, difficult tube change, tracheal stenosis,
tracheomalacia, tracheocutaneous/-esophageal
fistula)
 Minor complications (technical difficulties
without life-threatening event, cuff leak, hypoxemia,
stomal inflammation, stomal infection, minor
bleeding)
5. Notes: funding for trial (industry/independent/not
stated/name of sponsor), notable conflicts of interest
of trial authors (stated/not stated/how described)
All disagreements of the two review authors will be
resolved by consensus or by involving a third person.
Endpoints of the study
The combined primary endpoint will be the risk of po-
tentially life-threatening events including loss of airway,
false route, tracheal/esophageal injury, major bleeding,
gastric aspiration, pneumothorax/-mediastinum, subcuta-
neous emphysema, difficult tube change, other potentially
life-threatening events. All potentially life-threatening
events will be added to calculate the combined endpoint.
For each procedure, not more than one potentially life-threatening event will be counted to estimate the com-
bined primary endpoint.
Secondly, mortality intraoperatively and during the
first 24 h after the intervention will be assessed. Further-
more, complications such as technical difficulties, stomal
infection, stomal inflammation, and late complications
will be evaluated separately as well as the duration of the
procedure.
Subgroup analysis
To analyze which PDT technique is favorable, to assess
the concomitant diagnostic (bronchoscopy/ultrasound), to
examine the profession and experience of the performing
physician, and to evaluate the location of performance, the
following subgroup analyses are planned to be performed,
if sufficient data are available:
1. BDT versus ST
2. GWT versus ST
3. MDT versus ST
4. PDT versus ST
5. RDT versus ST
6. SSDT versus ST
7. TLT versus ST
8. Antegrade techniques (BDT, GWT, MDT, PDT,
SSDT) versus ST
9. Bronchoscopic or sonographic guided tracheostomy
versus no visual control during tracheostomy
10. Tracheotomy performed by surgeons versus
tracheotomy performed by other physicians
11. PDTs performed on the intensive care unit versus
in the operating theater
12. STs performed on the intensive care unit versus STs
in the operating theater
Assessment of the methodological quality of included
studies
The risk of bias will be assessed for each study using the
criteria outlined in the Cochrane Handbook for Systematic
Reviews of Interventions [23]. Any disagreement will be
solved by discussion or by involving a third reviewer. Each
of the following domains will be evaluated:
1. Random sequence generation
2. Allocation concealment
3. Blinding of participants and personnel
4. Blinding of outcome assessment
5. Incomplete outcome data
6. Selective outcome reporting
7. Other bias (e.g., baseline imbalance, early
termination of the trial, funding bias)
Each potential source of bias will be graded as high, low,
or unclear and a quote from the study report together with
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of bias table. In case of information of unpublished data or
correspondence with an author of an included trial, this will
be noted in the risk of bias table. The quality of the body of
evidence will be addressed using the specific evidence
grading system developed by the GRADE collaboration.
The following five considerations will be included: limita-
tions in the design, indirectness of evidence, unexplained
heterogeneity or inconsistency of results, imprecision of
results, and high probability of publication bias [24].
To assess the robustness of our conclusions, sensitivity
analysis will be conducted excluding studies with less
than the average number of positive judgements in the
risk of bias assessment.
The review will be conducted according to the published
protocol, and any deviations from it will be reported in the
“Differences between protocol and review” section of the
systematic review. In case of missing data, investigators or
study sponsors will be contacted.
Statistical analysis
Dichotomous data will be analyzed as absolute differences
with their 95 % confidence intervals and continuous data as
mean difference. Meta-analyses will only be performed
where this is meaningful, i.e., if the treatments, participants,
and the underlying clinical question are similar enough to
justify pooling.
In the case of continuous data, means and standard devi-
ations will be reported. When medians and interquartile
ranges are reported, the methods described by Higgins [23]
and by Hozo [25] to calculate means and standard devia-
tions will be used. The decision to conduct quantitative
synthesis with these data will be based upon individual
decision for each outcome.
Whenever sufficient data for a specific outcome are
provided, meta-analysis will be performed by the use of a
random effects model [26]. If substantial heterogeneity
(>75 %) is identified, this will be explored by pre-specified
subgroup analyses.
Assessment of heterogeneity
I2 statistics will be used to measure statistical heterogen-
eity among the trials in each analysis. An I2 < 25 % will
be considered a low heterogeneity and an I2 > 75 % will
be considered a high heterogeneity. If there is an ex-
treme level of heterogeneity, summary effect measures
will be interpreted with caution. Clinical heterogeneity
will be explored by assessing differences in baseline data,
performers’ discipline, type of percutaneous technique,
definitions of outcome parameters, and operative and/or
perioperative management. The presence of strong clin-
ical heterogeneity will be considered in the decision to
conduct quantitative synthesis of data or to perform
sensitivity analyses with a special focus.Trial authors will be contacted asking them to provide
missing outcome data if this is necessary. Where this will
be not possible, and the missing data is thought to intro-
duce serious bias, the impact of including such studies in
the overall assessment of results will be explored by a
sensitivity analysis. A funnel plot will be created and exam-
ined for asymmetry to explore possible publication bias.
Discussion
Most patients undergoing tracheostomy are critically ill
and even minor complications of the intervention can lead
to severe consequences in their already unstable health
condition. Thus, even small differences between the two
compared strategies seem to be relevant for both patients
and the healthcare system, even more when the common-
ness of this intervention is taken into account.
A combined primary endpoint was chosen for this study
assessing the potentially life-threatening events related to
the tracheostoma formation, as the overall risk of a possibly
lethal situation of the intervention was found to be the
most clinically and patient-relevant parameter. Addressing
several single complications of the intervention could not
satisfactorily answer the question, “Which strategy is more
beneficial?” Our chosen, clinically relevant endpoint has
not been used in any of the previous meta-analyses before,
and furthermore, all currently available studies have not
been evaluated.
To achieve the highest possible level of evidence, this
systematic review and proportional meta-analysis will in-
clude RCTs only. Assessment of methodological quality will
be performed according to the recommendations of the
Cochrane Handbook and the five GRADE’s considerations
will be applied.
Subanalysis of the different PDT techniques will help to
determine if any of the percutaneous dilatational methods
should not be considered anymore or if another technique
is preferable over the others. Patients undergoing emer-
gency tracheostomy and children will not be included, so
that they do not introduce heterogeneity. Furthermore,
because of the relevance and great acceptance of the two
strategies investigated, we still expect a sufficient sample
size in both study groups.
In case of low sample sizes in the different groups of the
various PDT techniques described above, the techniques
will be grouped in ante- and retrograde techniques. Thus,
at least for these formed groups of PDT techniques, valid
results are achievable.
To date, there is no gold standard for the strategy of
tracheostomy as evidence is poor. The findings of this
systematic review with proportional meta-analysis will
help to compare potentially life-threatening event rates
and procedure-related mortality in the two main ap-
proaches. This may influence daily practice and the data
may be implemented in treatment guidelines. Considering
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tients, they will particularly benefit from evidence-
based treatment.
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